Updates are available Correction dated 2019-04-11
Click to view Correction: https://doi.org/10.1038/s41564-019-0452-3
-
Authors
MacLean, Emily
Broger, Tobias http://orcid.org/0000-0002-7959-1055
Yerlikaya, Seda
Fernandez-Carballo, B. Leticia
Pai, Madhukar
Denkinger, Claudia M. http://orcid.org/0000-0002-7216-7067
- License Information
-
More Information
Article History
Received: 21 February 2018
Accepted: 18 January 2019
First Online: 25 February 2019
Change Date: 11 April 2019
Change Type: Correction
Change Details: In the original version of this Analysis, author Seda Yerlikaya was mistakenly spelled as Seda Yerliyaka. This has now been amended.
Competing interests
: T.B., S.Y., B.L.F.-C. and C.M.D. are employed by FIND. FIND is a not-for-profit foundation that supports the evaluation of publicly prioritized TB assays and the implementation of WHO-approved (guidance and prequalification) assays using donor grants. FIND has product evaluation agreements with several private sector companies that design diagnostics for TB and other diseases. These agreements strictly define FIND’s independence and neutrality vis-a-vis the companies whose products get evaluated and describe roles and responsibilities. M.P. serves on the WHO SAGE IVD Group and is a member of the Scientific Advisory Committee of FIND. M.P. and E.M. have no industry or financial conflicts.
